SENS home

Aubrey de Grey Contacter
Curriculum Publications Lectures
Financement Média

Initiatives du SENS
Pourquoi à la fois un prix et un institut?
Comment apporter votre aide
Prix Journal Institut

Préoccupations SENS
La surpopulation! Seulement pour les riches!
Despotes immortels! Se prendre pour Dieu!
Ce qui doit être dit! En plus encore...

Autres questions sur le SENS
Combien de temps en plus, à partir de quand?
Pourquoi vous faire confiance?
Que puis-je faire pour donner un coup de main?
Pourquoi "SENS"? En outre...

Rendez-vous du SENS
Tables rondes 1 2 3 4
Conférences 1 2

Les cibles du SENS
Technologies de transfert
Cellules Quand il y en a trop peu
Ou trop
Mutations Chromosomiques
Mitochondriales
Déchets A l'intérieur de la cellule
A l'extérieur de la cellule
Réticulation A l'extérieur de la cellule
Pourquoi sept et pas plus?

Sujets connexes
Articles Sites Liens généraux

Les publications d'Aubrey de Grey

La plupart des publications suivantes sont fournies ici sous forme de documents PDF; lorsque cela n'a pas été possible, il y a des liens vers les résumés. Les réimpressions sont disponibles sur demande.

Introduction pour les non-spécialistes
Vue d'ensemble de la Science sous-jacente à SENS
Contexte social de SENS incluant la biogérontologie
Prévention des mutations mitochondriales
Elimination des agrégats lysosomials
Un véritable remède contre le cancer
Eliminer les hybrides extracellulaires, les agrégats et les cellules indésirables
Les mutations mitochondriales et leurs effets
Autre


Introduction pour les non-spécialistes:

de Grey ADNJ. Une approche d'ingénieur au développement d'une véritable médecine anti-vieillissement.
Science's SAGE KE 2003; 2003(1):vp1. Aussi dans: Fontaine de Jouvence: les perspectives éthiques, religieuses et existentielles à un but biomédical (S.G. Post and R.H. Binstock, eds.), Oxford University Press, 2003, pp. 249-267. PDF

de Grey ADNJ. Echapper à la vitesse: pourquoi la perspective d'un allongement extrême de la vie humaine importe maintenant. PLoS Biol 2004; 2(6):723-726. PDF

de Grey ADNJ. La prévisibilité d'une véritable médecine anti-vieillissement. Dans: les Thérapeutiques médicales anti-vieillissement, volume 7 (R. Klatz, ed.), Académie américaine pour la médecine anti-vieillissement, 2005, pp. 59-68. PDF

La plupart de mes publications sont écrites pour un public de spécialistes: biogérontologistes ou autres biologistes, sauf celles indiquées ci-dessus, qui s'adressent à un public plus large. Commencez ici si vous êtes nouveau dans le domaine, et particulièrement si vous n'êtes pas biologiste.


Overviews of the science underlying SENS:

de Grey ADNJ, Ames BN, Andersen JK, Bartke A, Campisi J, Heward CB, McCarter RJM, Stock G. Time to talk SENS: critiquing the immutability of human aging. In: Increasing Healthy Life Span: Conventional Measures and Slowing the Innate Aging Process - Ninth Congress of the International Association of Biomedical Gerontology (D. Harman, ed.),
Annals NY Acad Sci 2002; 959:452-462. PDF

de Grey ADNJ. An engineer's approach to the development of real anti-aging medicine. Science's SAGE KE 2003; 2003(1):vp1. Also in: The Fountain of Youth: Ethical, Religious, and Existential Perspectives on a Biomedical Goal (S.G. Post and R.H. Binstock, eds.), Oxford University Press, 2004, pp. 249-267. PDF

de Grey ADNJ. Challenging but essential targets for genuine anti-ageing drugs. Expert Opinion on Therapeutic Targets 2003; 37(1):1-5. PDF

de Grey ADNJ. UK research on the biology of aging -- the next ten years. Lifespan 2003; 11(1):1-4. PDF

de Grey ADNJ. Foreseeable and more distant rejuvenation therapies. In: Aging Interventions and Therapies (S.I.S. Rattan, ed.), World Scientific, 2005, pp. 379-395. PDF

de Grey ADNJ. A strategy for postponing aging indefinitely. Studies in Health Technology and Informatics 2005; 118:209-219. PDF

de Grey ADNJ. Strategie per un invecchiamento transcurabile ingegnerizzato. In: Alterando il destino dell'umanità (Donghi P, ed.), Proceedings of the 2005 Spoletoscienza conference. Rome: Laterza & Figli, 2006, pp. 49-63. Translation by Bruna Tortorella. PDF (in English)


Social context of SENS, including within biogerontology:

de Grey ADNJ. Gerontologists and the media: the dangers of over-pessimism.
Biogerontology 2000;1(4):369-370. PDF

de Grey ADNJ, Gavrilov L, Olshansky SJ, Coles LS, Cutler RG, Fossel M, Harman SM. Antiaging technology and pseudoscience. Science 2002; 296(5568):656. PDF

de Grey ADNJ, Baynes JW, Berd D, Heward CB, Pawelec G, Stock G. Is human aging still mysterious enough to be left only to scientists? BioEssays 2002; 24(7):667-676. PDF

de Grey ADNJ. Fear of misrepresentation cannot justify silence about foreseeable life-extension biotechnology. BioEssays 2003; 25(1):94-95. PDF

de Grey ADNJ. The foreseeability of real anti-aging medicine: focusing the debate. Exp Gerontol 2003; 38(9):927-934. PDF

de Grey ADNJ. Biogerontologists' duty to discuss timescales publicly. Annals NY Acad Sci 2004; 1019:542-545. PDF

de Grey ADNJ. Escape velocity: why the prospect of extreme human life extension matters now. PLoS Biol 2004; 2(6):723-726. PDF

de Grey ADNJ. The war on aging. In: The Scientific Conquest of Death (B.J. Klein et al., eds.), Libros en Red, 2004, pp. 17-29. PDF Also translated into Spanish by Ana Centeno: "La guerra contra el envejecimiento". PDF

de Grey ADNJ. Leon Kass: quite substantially right. Rejuvenation Res 2004; 7(2):89-91. PDF

de Grey ADNJ. Three self-evident life-extension truths. Rejuvenation Res 2004; 7(3):165-167. PDF

de Grey ADNJ. Aging, childlessness or overpopulation: the future's right to choose. Rejuvenation Res 2004; 7(4):237-238. PDF

de Grey ADNJ. Life extension, human rights, and the rational refinement of repugnance. J Med Ethics 2005; 31(11):659-663. PDF

de Grey ADNJ. Resistance to debate on how to postpone ageing is delaying progress and costing lives. EMBO Rep 2005; 6(S1):S49-S53. PDF

de Grey ADNJ. Like it or not, life-extension research extends beyond biogerontology. EMBO Rep 2005; 6(11):1000. PDF

de Grey ADNJ. When and where to publish important findings: a casualty of biogerontology's rise to respectability. Rejuvenation Res 20055; 8(1):1-2. PDF

de Grey ADNJ. The rate of aging": a counterproductively undefinable term. Rejuvenation Res 2005; 8(2):77-78. PDF

de Grey ADNJ. The ethical status of efforts to postpone aging: a reply to Hurlbut. Rejuvenation Res 2005; 8(3):129-130. PDF

de Grey ADNJ. The SENS challenge: $20,000 says the foreseeable defeat of aging is not laughable. Rejuvenation Res 2005; 8(4):207-210. PDF

de Grey ADNJ. The foreseeability of real anti-aging medicine. In: Anti-Aging Medical Therapeutics, volume 7 (R. Klatz, ed.), American Academy for Anti-Aging Medicine, 2005, pp. 59-68. PDF

de Grey ADNJ. Extrapolaholics Anonymous: why demographers' rejections of a huge rise in cohort life expectancy in this century are overconfident. Annals NY Acad Sci 2006; 1067:83-93. PDF

de Grey ADNJ. Compression of morbidity: the hype and the reality, part 1. Rejuvenation Res 2006; 9(1):1-2. PDF

de Grey ADNJ. Compression of morbidity: the hype and the reality, part 2. Rejuvenation Res 2006; 9(2):167-168. PDF


Obviation of mitochondrial mutations:

de Grey ADNJ. Are those 13 proteins really unimportable? In: From Symbiosis to Eukaryotism - Endocytobiology VII (E. Wagner et al., eds.), Geneva University Press, 1999, pp. 489-502.

de Grey ADNJ. Mitochondrial gene therapy: an arena for the biomedical use of inteins.
Trends Biotechnol 2000; 18(9):394-399. PDF

de Grey ADNJ. Response to "approaches and limitations to gene therapy for mitochondrial diseases," Antioxid. Redox Signal. 2001;3:451-460. Antioxid Redox Signal 2001; 3(6):1153-1155. PDF

de Grey ADNJ. Inter-species therapeutic cloning: the looming problem of mitochondrial DNA and two possible solutions. Rejuvenation Res 2004; 7(2): 95.98. PDF

de Grey ADNJ. Forces maintaining organellar genomes: is any as strong as genetic code disparity or hydrophobicity? BioEssays 2005; 27(4):436-446. PDF


Removal of lysosomal aggregates:

de Grey ADNJ. Bioremediation meets biomedicine: therapeutic translation of microbial catabolism to the lysosome.
Trends Biotechnol 2002; 20(11): 452-455. PDF

de Grey ADNJ, Alvarez PJJ, Brady RO, Cuervo AM, Jerome WG, McCarty PL, Nixon RA, Rittmann BE, Sparrow JR. Medical bioremediation: prospects for the application of microbial catabolic diversity to aging and several major age-related diseases. Ageing Res Rev 2005; 4(3):315-338. PDF

de Grey ADNJ. Lysosomal enhancement with microbial hydrolases: a novel strategy for removing protein aggregates. In: New Trends in Alzheimer and Parkinson Disorders: ADPD 2005 (A. Fisher et al., eds.), Medimond 2005, pp. 51-54. PDF

de Grey ADNJ. Appropriating microbial catabolism: a proposal to treat and prevent neurodegeneration. Neurobiol Aging 2006; 27(4):589-595. PDF


A real cure for cancer:

de Grey ADNJ, Campbell FC, Dokal I, Fairbairn LJ, Graham GJ, Jahoda CAB, Porter ACG. Total deletion of in vivo telomere elongation capacity: an ambitious but possibly ultimate cure for all age-related human cancers.
Annals NY Acad Sci 2004; 1019:147-170. PDF

de Grey ADNJ. Whole-body interdiction of lengthening of telomeres: a proposal for cancer prevention. Front Biosci 2005; 10:2420-2429. PDF


Removing extracellular crosslnks and aggregates and unwanted cells:

de Grey ADNJ. Challenging but essential targets for genuine anti-ageing drugs.
Expert Opinion on Therapeutic Targets 2003; 37(1):1-5. PDF

de Grey ADNJ. Foreseeable pharmaceutical repair of age-related extracellular damage. Current Drug Targets, in press. PDF


Mitochondrial mutations and their effects:

de Grey ADNJ. A proposed refinement of the mitochondrial free radical theory of aging.
BioEssays 1997; 19(2):161-166. PDF

de Grey ADNJ. A mechanism proposed to explain the rise in oxidative stress during aging. J Anti-Aging Med 1998; 1(1):53-66. PDF

de Grey ADNJ. The mitochondrial free radical theory of aging. Austin, TX: Landes Bioscience, 1999, 212pp, hardcover (ISBN 1-57059-564-X).

de Grey ADNJ. The non-correlation between maximum longevity and enzymatic antioxidant levels among homeotherms; implications for retarding human aging. J Anti-Aging Med 2000; 3(1):25-36. PDF

de Grey ADNJ. The reductive hotspot hypothesis: an update. Arch Biochem Biophys 2000; 373(1):295-301. PDF

de Grey ADNJ. The reductive hotspot hypothesis of mammalian aging: membrane metabolism magnifies mutant mitochondrial mischief. Eur J Biochem 2002; 269(8):2003-2009. PDF

de Grey ADNJ. Mitochondrial mutations in vertebrate aging. In: Oxidative stress and aging: advances in basic science, diagnostics, and intervention (R.G. Cutler and H. Rodriguez, eds.), World Scientific Publishing, 2002, pp. 437-451. PDF

de Grey ADNJ. Mechanisms underlying the age-related accumulation of mutant mitochondrial DNA. In: Genetics of mitochondrial diseases (I.J. Holt, ed.), Oxford University Press, 2003, pp. 247-275. PDF

de Grey ADNJ. Mitochondria in homeotherm aging: will detailed mechanisms consistent with the evidence now receive attention? Aging Cell 2004; 3(2):77. PDF

de Grey ADNJ. Mitochondrial mutations in mammalian aging: an over-hasty about-turn? Rejuvenation Res 2004; 7(3):171-174. PDF

de Grey ADNJ. Reactive oxygen species production in the mitochondrial matrix: implications for the mechanism of mitochondrial mutation accumulation. Rejuvenation Res 2005; 8(1):13-17. PDF

de Grey ADNJ. The plasma membrane redox system: a candidate source of aging-related oxidative stress. AGE J Am Aging Assoc 2005; 27(2):129-138. PDF

de Grey ADNJ. Free radicals in aging: causal complexity and its biomedical implications. Free Radic Res 2006, in press. PDF


Other:

de Grey ADNJ. Incorporation of transmembrane hydroxide transport into the chemiosmotic theory.
Bioelectrochem Bioenerg 1999; 49(1-2):43-50. PDF

de Grey ADNJ. Biologists abandon Popper at their peril. BioEssays 2000; 22(2):206-207. PDF

de Grey ADNJ. A proposed mechanism for the lowering of mitochondrial electron leak by caloric restriction. Mitochondrion 2001; 1(2):129-139. PDF

de Grey ADNJ. UK research on the biology of aging. Exp Gerontol 2001; 37(1):1-7. PDF

de Grey ADNJ. Response to "telomere shortening with aging in human liver". J Gerontol A Biol Sci Med Sci 2001; 56(6):B237-B238. PDF

de Grey ADNJ. HO2: the forgotten radical. DNA Cell Biol 2002; 21(4):251-257. PDF

de Grey ADNJ. Critique of the demographic evidence for "late-life non-senescence". Biochem Soc Trans 2003; 31(2):452-454. PDF

de Grey ADNJ. A proposal for the overall structure of the mammalian plasma membrane redox system. Protoplasma 2003; 221(1-2):3-9. PDF

de Grey ADNJ. Overzealous maximum-likelihood fitting falsely convicts the slope heterogeneity hypothesis. Exp Gerontol 2003; 38(8):921-923. PDF

de Grey ADNJ. Falsifying falsifications: the most critical task of theoreticians in biology. Medical Hypotheses 2004; 62(6):1012-1020. PDF

de Grey ADNJ. The unfortunate influence of the weather on the rate of aging: why human caloric restriction or its emulation may only extend life expectancy by 2-3 years. Gerontology 2005; 51(2):73-82. PDF

de Grey ADNJ. Gene therapy. In: Encyclopedia of Aging, Fourth Edition (R. Schulz et al., eds.), Springer, 2006, in press. PDF

de Grey ADNJ. Do accumulating nuclear mutations or epimutations influence mammalian aging over and above cancer? Mech Ageing Dev 2006, in press. PDF



Les problèmes éventuels ou les questions à propos du site devraient être reportés au: Dr. de Grey